Welcome to our dedicated page for Health In Tech SEC filings (Ticker: HIT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Health In Tech, Inc. (Nasdaq: HIT) files a range of reports and disclosures with the U.S. Securities and Exchange Commission as a Nasdaq-listed, Nevada-incorporated InsurTech platform company. Its SEC filings provide detailed information on financial performance, governance, equity plans, and material corporate events related to its AI-enabled healthcare and insurance marketplace.
On this page, you can review Health In Tech’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss revenues, operating expenses, cash flows, and segment-related data for its insurance technology platform. These filings also describe risk factors, business strategy, and the company’s focus on process simplification and automation for insurers, brokers, and TPAs.
Health In Tech’s current reports on Form 8-K document specific events such as earnings announcements, investor presentations, stockholder meetings, equity incentive plan amendments, restricted stock awards tied to new initiatives and programs, and changes in executive roles. For example, 8-K filings describe the company’s annual meeting voting results, grants of restricted stock for new initiatives, and terminations or appointments of certain officers.
Investors interested in ownership and governance can use proxy materials such as the DEF 14A definitive proxy statement to understand board elections, equity plan proposals, auditor ratification, and voting structures for Class A and Class B common stock. These documents outline how Health In Tech manages compensation, board composition, and stockholder rights.
Stock Titan enhances access to these filings with AI-powered summaries that explain key points from lengthy documents, helping users quickly interpret complex sections of 10-Ks, 10-Qs, and 8-Ks. Real-time updates from EDGAR ensure that new filings for HIT appear promptly, while structured views of forms such as 8-K and proxy statements make it easier to track developments in Health In Tech’s InsurTech operations, capital structure, and governance over time.
Health In Tech, Inc. furnished an investor presentation describing its AI-powered marketplace that helps small and mid-sized businesses access self-funded health plans without taking plan or underwriting risk. The company reported 2025 revenue of $33.3M, up from $19.5M in 2024, and 2025 adjusted EBITDA of $4.1M versus $2.3M a year earlier. As of December 31, 2025, it had 22,515 enrolled employees, 795 business clients, and 858 brokers and agencies, with stockholders’ equity of $17.1M. The presentation reiterates 2026 revenue guidance of $45M–$50M, highlights a fee-based model with no claims exposure, and emphasizes plans to drive growth through more brokers, products, and carrier relationships.
Health In Tech, Inc. completed a private investment in public equity financing, raising gross proceeds of approximately $7.0 million. The company issued 5,600,000 shares of common stock at $1.25 per share to institutional and accredited investors in a private placement.
Management states that the additional capital is intended to support the next phase of its AI-enabled InsurTech platform development, fund key technology initiatives, and bring new product capabilities to market. The financing also brings new long-term institutional investors into the shareholder base, which leadership believes can enhance market visibility and support its broader capital markets strategy.
Health In Tech, Inc. entered into a securities purchase agreement for a private investment in public equity (PIPE) covering 5,600,000 common shares at $1.25 per share, for expected gross proceeds of about $7.0 million before fees and expenses.
The company plans to use net proceeds to expand sales distribution, advance technology development, support new product development, and for general corporate purposes and working capital. The PIPE is expected to close on or about March 27, 2026, and the investors will receive resale registration rights for the shares.
Health In Tech, Inc. is an AI-enabled insurance technology company that runs a marketplace for self-funded employer health plans and stop-loss insurance. Its core eDIYBS platform lets brokers upload census data and generate medically underwritten, bindable quotes, often in about two minutes, using third-party AI models and proprietary risk scoring.
The business is vertically integrated through three subsidiaries: SMR (program design and plan management), ICE (MGU underwriting and SaaS quoting), and HI Card (a digital health and claims platform with a 50‑state Medicare-based provider network). For 2025, SMR and ICE contributed 79.4% and 20.6% of revenue, with HI Card at 0.0%.
As of December 31, 2025, the company worked with 583 brokers, 12 TPAs and 263 agencies in 40 states, serving 795 employer clients and 22,515 covered employees. Management reports maintaining profitability while revenue grew 71% year over year from 2024 to 2025. Key risks include dependence on carriers and distribution partners, heavy reliance on third-party AI data vendors, complex regulation of health data and insurance services, cybersecurity and privacy exposure, and execution challenges as the company scales its platform and enters new product lines and markets.
Health In Tech, Inc. reported strong growth for 2025, with total revenue of $33.3 million and net income of $1.28 million, as the business scaled its AI-enabled InsurTech platform. Management highlighted that full-year revenue grew 71% year over year.
The company issued an upbeat 2026 outlook, guiding for revenue between $45 million and $50 million, implying approximately 35%–50% growth driven by expanding use of its underwriting marketplace and new features launched in January 2026. Adjusted EBITDA for 2025 was $4.11 million, and cash and cash equivalents were $7.67 million as of December 31, 2025.
Health In Tech, Inc. filed an initial ownership report for Chief Technology Officer Rajagopalan Sridharan, showing beneficial ownership of 20,000 shares of Class A common stock. These are restricted shares granted under the Health in Tech Equity Incentive Plan and vest in equal monthly installments over twelve months, starting on February 23, 2026, subject to his continued service with the company.
Health In Tech, Inc. reported that Chief Growth Officer Hasan Zain Syed received 200,000 restricted shares of Class A common stock on January 6, 2026 under the Health in Tech Equity Incentive Plan. These shares are tied to two proposed issuer transactions. Half of the grant vests in equal monthly installments over 12 months starting at the closing of the first transaction, and the other half vests monthly over 12 months starting at the closing of the second transaction, in each case subject to continued service. If either transaction does not close within 24 months after January 6, 2026, the unvested shares relating to that transaction will be automatically forfeited without payment. Following this grant, Syed beneficially owns 220,000 restricted shares of Class A common stock, held directly.
Health In Tech, Inc. reported that Chief Executive Officer, director and 10% owner Tim Johnson received a grant of 1,000,000 restricted shares of Class A Common Stock on January 6, 2026 at a price of $0 per share under the Health In Tech Equity Incentive Plan. The grant is tied to two proposed issuer transactions: half of the shares vest in equal monthly installments over 12 months starting at the closing of the first transaction, and the other half vest monthly over 12 months starting at the closing of the second transaction, in each case subject to continued service.
If either transaction does not close within 24 months after January 6, 2026, any unvested shares relating to that transaction will be automatically forfeited without consideration. Following this award, Johnson beneficially owns 23,549,741 shares of Class A Common Stock, including 1,126,130 restricted shares and 22,423,611 unrestricted shares.
Health In Tech, Inc. officer and director LinLin Qian reported an award of 1,000,000 restricted shares of Class A Common Stock on January 6, 2026 under the Health in Tech Equity Incentive Plan at a price of $0 per share. The grant is tied to two proposed issuer transactions, with half of the shares vesting in equal monthly installments over 12 months after the closing of the first transaction and the other half vesting monthly over 12 months after the closing of the second transaction, subject to continued service.
If either transaction does not close within 24 months after January 6, 2026, any unvested shares related to that transaction will be forfeited without consideration. Following this grant, Qian beneficially owns 9,128,555 Class A shares, including 1,119,130 restricted shares and 8,009,425 unrestricted shares, and also holds but does not count here 2,700,000 Class B shares and 711,510 options to purchase Class A shares.
Health In Tech, Inc. reported that its Chief Technology Officer, Imran Yousuf, was terminated from his position on November 25, 2025. The company states that the termination was without cause and was not the result of any disagreement regarding its operations, policies, or practices. This update focuses solely on the leadership change and does not describe any changes to the company’s strategy or business activities.